Intrathecal baclofen withdrawal: a case report and review of the literature

被引:44
作者
Alden, TD
Lytle, RA
Park, TS
Noetzel, MJ
Ojemann, JG
机构
[1] Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Neurosurg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Neurol, St Louis, MO 63110 USA
关键词
spasticity; implantable infusion pumps; intrathecal baclofen; withdrawal; complications;
D O I
10.1007/s00381-002-0634-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Spasticity is an endpoint of a variety of neurologic disorders with upper motor neuron damage. There have been several studies demonstrating improvement in spasticity through administration of intrathecal baclofen. Withdrawal from oral baclofen has been well described. Intrathecal baclofen withdrawal has been less frequently reported. We present a case of withdrawal after intrathecal baclofen pump catheter failure. Patient: A 14-year-old boy presented with fevers, which were thought to be related to recent spine surgery and possible pneumonia. Eventual workup revealed evidence of intrathecal baclofen withdrawal owing to pump catheter failure. His fevers, with temperatures of up to 40 C, and painful muscle spasms resolved and his clinical condition improved after pump exploration and resumption of intrathecal delivery. Conclusions: Intrathecal baclofen withdrawal can be life threatening. Prompt recognition and restoration of an adequate intrathecal baclofen dose is essential for recovery.
引用
收藏
页码:522 / 525
页数:4
相关论文
共 40 条
[1]  
ABEL NA, 1994, ARCH PHYS MED REHAB, V75, P54
[2]   Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure - A case report [J].
Al-Khodairy, AT ;
Vuagnat, H ;
Uebelhart, D .
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 1999, 78 (03) :272-277
[3]   Intrathecal baclofen in cerebral palsy movement disorders [J].
Albright, AL .
JOURNAL OF CHILD NEUROLOGY, 1996, 11 :S29-S35
[4]  
ARMSTRONG RW, 1992, DEV MED CHILD NEUROL, V34, P731
[5]   Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin [J].
Armstrong, RW ;
Steinbok, P ;
Cochrane, DD ;
Kube, SD ;
Fife, SE ;
Farrell, K .
JOURNAL OF NEUROSURGERY, 1997, 87 (03) :409-414
[6]   LONG-TERM INTRATHECAL BACLOFEN THERAPY IN PATIENTS WITH INTRACTABLE SPASTICITY [J].
BECKER, WJ ;
HARRIS, CJ ;
LONG, ML ;
ABLETT, DP ;
KLEIN, GM ;
DEFORGE, DA .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1995, 22 (03) :208-217
[7]  
Broseta J, 1989, Acta Neurochir Suppl (Wien), V46, P39
[8]   CHRONIC INTRATHECAL BACLOFEN ADMINISTRATION IN SEVERE SPASTICITY [J].
BROSETA, J ;
GARCIAMARCH, G ;
SANCHEZLEDESMA, MJ ;
ANAYA, J ;
SILVA, I .
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 1990, 54-5 :147-153
[9]   INTRATHECAL BACLOFEN - A MULTICENTER CLINICAL COMPARISON OF THE MEDTRONICS PROGRAMMABLE, CORDIS SECOR AND CONSTANT INFUSION INFUSAID DRUG-DELIVERY SYSTEMS [J].
GARDNER, B ;
JAMOUS, A ;
TEDDY, P ;
BERGSTROM, E ;
WANG, D ;
RAVICHANDRAN, G ;
SUTTON, R ;
URQUART, S .
PARAPLEGIA, 1995, 33 (10) :551-554
[10]   Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial [J].
Gilmartin, R ;
Bruce, D ;
Storrs, BB ;
Abbott, R ;
Krach, L ;
Ward, J ;
Bloom, K ;
Brooks, WH ;
Johnson, DL ;
Madsen, JR ;
McLaughlin, JF ;
Nadell, J .
JOURNAL OF CHILD NEUROLOGY, 2000, 15 (02) :71-77